Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Cervical Cancer

  Free Subscription


09.06.2025

1 Adv Sci (Weinh)
1 Am J Case Rep
1 Am J Trop Med Hyg
1 Ann Surg Oncol
1 Anticancer Drugs
1 Biochem Biophys Res Commun
1 Biochem J
1 Biochim Biophys Acta Mol Cell Res
1 Bioorg Chem
1 BJOG
1 BMC Med
1 BMC Public Health
3 BMJ Open
1 Brachytherapy
2 Cancer Epidemiol
1 Cancer Genet
1 Cancer Immunol Immunother
1 Cancer Lett
2 Cancer Pathog Ther
1 Cancer Rep (Hoboken)
1 Cien Saude Colet
1 Crit Rev Immunol
1 Crit Rev Oncol Hematol
1 Cureus
1 Curr Cancer Drug Targets
2 Diagn Cytopathol
1 Discov Oncol
1 F1000Res
1 Food Chem Toxicol
1 Front Genet
2 Front Immunol
2 Front Oncol
1 Front Pharmacol
1 Front Public Health
1 Georgian Med News
1 Gulf J Oncolog
1 Gynecol Oncol
1 Health Promot Perspect
1 Health SA
1 Hum Vaccin Immunother
1 Int J Biol Macromol
2 Int J Gynecol Cancer
1 Int J Radiat Biol
1 Int J Radiat Oncol Biol Phys
1 Int J Surg Pathol
1 Int J Womens Health
1 Intern Med
1 J Community Health
1 J Gen Intern Med
1 J Korean Med Sci
1 J Nanobiotechnology
1 J Natl Cancer Inst
1 J Surg Oncol
2 JAMA Intern Med
1 JCO Glob Oncol
1 Jpn J Radiol
2 Kathmandu Univ Med J (KUMJ)
1 Laryngorhinootologie
1 Microbiol Spectr
1 Mol Diagn Ther
1 Mol Med
1 Mol Med Rep
1 MSMR
1 Niger J Clin Pract
1 Nucl Med Commun
1 Phys Med Biol
2 PLoS One
1 Protein Cell
1 Radiat Oncol
1 Semin Oncol Nurs
1 Surg Pract Sci
1 Turk J Obstet Gynecol
2 Vaccine
1 Virol J


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Adv Sci (Weinh)

  1. XU T, Zhang Y, Li S, Dai C, et al
    Deep Learning-Enhanced Hand-Driven Microfluidic Chip for Multiplexed Nucleic Acid Detection Based on RPA/CRISPR.
    Adv Sci (Weinh). 2025;12:e2414918.
    PubMed         Abstract available


    Am J Case Rep

  2. WALUYO ST, Yuseran H, Armanza F, Manalu FFEC, et al
    Emergency Radiation Therapy for Hemorrhage in Botryoides Sarcoma: A Pediatric Case Report.
    Am J Case Rep. 2025;26:e946434.
    PubMed         Abstract available


    Am J Trop Med Hyg

  3. MBABAZI E, Munyemana JB, Mukashema J, Bazimaziki E, et al
    Prevalence of Human Papillomavirus and Genotype Correlation with Cervical Lesions at the University Teaching Hospital of Kigali.
    Am J Trop Med Hyg. 2025;112:1335-1340.
    PubMed         Abstract available


    Ann Surg Oncol

  4. CHEN Q, Deng D, Zhu H, Li S, et al
    ASO Author Reflections: Multi-omic and Single-Cell Insights into the Age-Related Molecular Landscape of Cervical Cancer.
    Ann Surg Oncol. 2025 May 31. doi: 10.1245/s10434-025-17543.
    PubMed        


    Anticancer Drugs

  5. SUN C, Meng X, Cui X, Liang S, et al
    APG-115 synergizes with bortezomib to induce apoptosis in cervical cancer cells.
    Anticancer Drugs. 2025 Jun 3. doi: 10.1097/CAD.0000000000001735.
    PubMed         Abstract available


    Biochem Biophys Res Commun

  6. PANG G, Ruan X, Yao W, Cao M, et al
    Significance of PFKFB4 and gene risk signature in cervical cancer prognosis and progression.
    Biochem Biophys Res Commun. 2025;775:152084.
    PubMed         Abstract available


    Biochem J


  7. Deregulation of LIMD1-VHL-HIF-1alpha-VEGF pathway is associated with different stages of cervical cancer.
    Biochem J. 2025;482:BCJ20170649.
    PubMed        


    Biochim Biophys Acta Mol Cell Res

  8. JAISWAL S, Mishra V, Majumder S, Wangikar PP, et al
    Metabolomic profiling reveals grade-specific niacinamide accumulation and its therapeutic potential via SIRT1-CD38-EMT axis modulation in cervical cancer progression.
    Biochim Biophys Acta Mol Cell Res. 2025;1872:119994.
    PubMed         Abstract available


    Bioorg Chem

  9. YANG Z, Liu Z, Ablise M, Jia J, et al
    Design, synthesis, and in vitro and in vivo anti-drug resistant cervical cancer activity of novel licochalcone A derivatives based on dual targeting of VEGFR-2/P-gp.
    Bioorg Chem. 2025;163:108639.
    PubMed         Abstract available


    BJOG

  10. VAN DE SANDE AJM, van Baars R, Koeneman MM, Gerestein CG, et al
    Topical imiquimod treatment of residual or recurrent cervical intraepithelial neoplasia lesions (TOPIC-2): A randomised controlled trial.
    BJOG. 2025;132:1056-1064.
    PubMed         Abstract available


    BMC Med

  11. TRANBERG M, Van Keer S, Jensen JS, Norgaard P, et al
    High-risk human papillomavirus testing in first-void urine as a novel and non-invasive cervical cancer screening modality-a Danish diagnostic test accuracy study.
    BMC Med. 2025;23:327.
    PubMed         Abstract available


    BMC Public Health

  12. SATHIYASEELAN G, Hashim SM, Nawi AM
    Sociocultural factors influencing women's adherence to colorectal, breast, and cervical cancer screening: a systematic review.
    BMC Public Health. 2025;25:2034.
    PubMed         Abstract available


    BMJ Open

  13. CULLIMORE V, Newhouse R, Baker-Rand H, Brentnall AR, et al
    Postnatal instead of normally-timed cervical screening (PINCS-1): a protocol for a feasibility study of paired-sample cervical screening and urine self-sampling at 6 weeks and 12 weeks postnatal in the UK.
    BMJ Open. 2025;15:e092701.
    PubMed         Abstract available

  14. FARAVEL K, Demontoy S, Jarlier M, De-Meric-de-Bellefon M, et al
    Impact of an educational physiotherapy-yoga intervention on perceived stress in women treated with brachytherapy for cervical cancer: a randomised controlled mixed study protocol (KYOCOL).
    BMJ Open. 2025;15:e098570.
    PubMed         Abstract available

  15. MORSEU-DIOP A, Butler T, Anderson K, Brotherton J, et al
    Stakeholder perspectives on HPV vaccination uptake among Aboriginal and Torres Strait Islander adolescents via the school immunisation programmes in Queensland: a qualitative study.
    BMJ Open. 2025;15:e097518.
    PubMed         Abstract available


    Brachytherapy

  16. CHINO J, Erickson B, Gaffney D, Hsu IC, et al
    The American Brachytherapy Society (ABS) consensus guidance for hybrid intracavitary interstitial brachytherapy for locally advanced cervical cancer.
    Brachytherapy. 2025 May 29:S1538-4721(25)00086.
    PubMed         Abstract available


    Cancer Epidemiol

  17. HONG SW, Yoon KJ, Kang JH
    Interplay between human papillomavirus infection, cervical cancer history, and the incidence of oral cancer: A cohort study.
    Cancer Epidemiol. 2025;97:102858.
    PubMed         Abstract available

  18. HOUPERT R, Sylvestre E, Bouhnik AD, Ben-Diane MK, et al
    Burden of cervical cancer in Martinique, 2012-2021.
    Cancer Epidemiol. 2025;97:102857.
    PubMed         Abstract available


    Cancer Genet

  19. HE D, Lv Q, Li B, Xu M, et al
    Study on the correlation between BRCA1 gene polymorphism and hrHPV infection in cervical precancerous lesions.
    Cancer Genet. 2025;294-295:99-110.
    PubMed         Abstract available


    Cancer Immunol Immunother

  20. LI X, Cheng Y, Ji M, Liu J, et al
    Single-cell RNA sequencing analysis reveals a lack of CXCL13(+) T cell subsets associated with the recurrence of cervical squamous cell carcinoma following concurrent chemoradiotherapy.
    Cancer Immunol Immunother. 2025;74:235.
    PubMed         Abstract available


    Cancer Lett

  21. AO K, Yin M, Lyu X, Xiao Y, et al
    Corrigendum to "METTL3-mediated HSPA9 m6A modification promotes malignant transformation and inhibits cellular senescence by regulating exosomal mortalin protein in cervical cancer" [Cancer Lett. 587 (2024) 216658].
    Cancer Lett. 2025 Jun 3:217827. doi: 10.1016/j.canlet.2025.217827.
    PubMed        


    Cancer Pathog Ther

  22. JEYARAJ G
    Commentary on the "Relationship between visceral obesity and prognosis in patients with stage IVB cervical cancer receiving radiotherapy and chemotherapy".
    Cancer Pathog Ther. 2025;3:269-270.
    PubMed        

  23. MURUGAN R
    Insights on the prognostic value of visceral obesity in stage IVB cervical cancer treatment.
    Cancer Pathog Ther. 2025;3:267-268.
    PubMed        


    Cancer Rep (Hoboken)

  24. ZHANG W, Ge Y, Yao L, Yan Q, et al
    Changes of Microbiome in Human Papillomavirus Infection and Cervical Cancer: A Systematic Review and Meta-Analysis.
    Cancer Rep (Hoboken). 2025;8:e70246.
    PubMed         Abstract available


    Cien Saude Colet

  25. CORREA JUNIOR AJS, Santana ME, Araujo JS, Prates PEG, et al
    ChatGPT SMART Goals for collaborative practices in the Global Strategy to Accelerate the Elimination of Cervical Cancer.
    Cien Saude Colet. 2025;30:e00662025.
    PubMed         Abstract available


    Crit Rev Immunol

  26. DA FONSECA DO, Puga MAM, Gubert VT, Pereira EFV, et al
    Cellular Immune Response to High-Risk Human Papillomavirus Infection: A Systematic Review.
    Crit Rev Immunol. 2025;45:33-49.
    PubMed         Abstract available


    Crit Rev Oncol Hematol

  27. DA SILVA JL, de Miranda AVSS, Arruda GV, de Andrade DAP, et al
    Stereotactic Body Radiotherapy as an Alternative to Brachytherapy in Cervical Cancer (SCORE): a Systematic Review and Meta-analysis.
    Crit Rev Oncol Hematol. 2025 Jun 1:104789. doi: 10.1016/j.critrevonc.2025.104789
    PubMed         Abstract available


    Cureus

  28. OKU Y, Itou S, Wakamatsu S, Niiyama Y, et al
    Investigation of Dosimetric Evaluation and Treatment Planning Time of Inverse Planning Optimization in Combined Intracavitary and Interstitial Brachytherapy for Cervical Cancer.
    Cureus. 2025;17:e83330.
    PubMed         Abstract available


    Curr Cancer Drug Targets

  29. ZHANG D, Fu R, Sun G, Yan J, et al
    Comprehensive Pan-cancer Analysis and Experimental Verification of EGLN Family: Potential Biomarkers in Cervical Cancer.
    Curr Cancer Drug Targets. 2025 Jun 3. doi: 10.2174/0115680096362252250527060004.
    PubMed         Abstract available


    Diagn Cytopathol

  30. JAMSHIDI M, Zare Karizi S, Baghizadeh H, Ezzatizadeh V, et al
    Determination of Prevalence and Genotype Distribution of High-Risk Human Papillomavirus in Varamin (Iran).
    Diagn Cytopathol. 2025;53:325-332.
    PubMed         Abstract available

  31. MA J, Yang M, Huang G
    Human Papillomavirus Prevalence and Genotype Distribution Among Women With Cervical Cytological Abnormalities in Urumqi, Xinjiang, China.
    Diagn Cytopathol. 2025;53:315-324.
    PubMed         Abstract available


    Discov Oncol

  32. DING W, Liu S, Zhang H, Ding H, et al
    Identification and validation of a thirteen-gene signature based on ubiquitin related genes in cervical cancer.
    Discov Oncol. 2025;16:1000.
    PubMed         Abstract available


    F1000Res

  33. SRIRAM S, Jayakumar AD, Gollapalli PK, Chandrasekar S, et al
    Demand-side barriers and economic burden in accessing Human Papillomavirus screening for cervical cancer prevention in rural India: Evidence from a cross-sectional study.
    F1000Res. 2025;13:630.
    PubMed         Abstract available


    Food Chem Toxicol

  34. LI L, Zhao Y, Li X, Tian M, et al
    Osthole inhibits proliferation and induces autophagy-dependent ferroptosis of cervical cancer cells through induction of TFR1.
    Food Chem Toxicol. 2025;203:115577.
    PubMed         Abstract available


    Front Genet

  35. HUANG B, Zheng J, Chen B, Wu M, et al
    Analysis of the correlation between RFC4 expression and tumor immune microenvironment and prognosis in patients with cervical cancer.
    Front Genet. 2025;16:1514383.
    PubMed         Abstract available


    Front Immunol

  36. ZHANG Y, Zhu J, Hu K, Qiu J, et al
    Multi-omics analyses construct an inflammatory response based prognostic gene signature for cervical cancer and suggest tumor infiltrating monocytes subgroups as key players.
    Front Immunol. 2025;16:1563593.
    PubMed         Abstract available

  37. ZHANG W, Liu YM, Li D, Liu S, et al
    Research progress on tumor-infiltrating lymphocyte therapy for cervical cancer.
    Front Immunol. 2025;16:1524842.
    PubMed         Abstract available


    Front Oncol

  38. MUGISHA NM, Pinder LF, Menon MP
    Editorial: Cervical screening awareness week 2023: integrating cervical cancer screening and precancer treatments.
    Front Oncol. 2025;15:1614832.
    PubMed        

  39. SUN C, Zhang J, Pan L, Yao S, et al
    Innovative nomogram for cervical cancer prediction: integrating high-risk HPV infection, p53 genotype, and blood routine parameters.
    Front Oncol. 2025;15:1541928.
    PubMed         Abstract available


    Front Pharmacol

  40. ZENG S, Li X, Xiao S, Yang P, et al
    The efficacy and safety of Tisotumab vedotin in the treatment of recurrent/metastatic cervical cancer: a systematic review and meta-analysis of single-arm studies.
    Front Pharmacol. 2025;16:1538980.
    PubMed         Abstract available


    Front Public Health

  41. KONG F, Yan Z, Gao L, Long J, et al
    Study on the relationship between vaginal dose and radiation-induced vaginal injury following cervical cancer radiotherapy, and model development.
    Front Public Health. 2025;13:1585481.
    PubMed         Abstract available


    Georgian Med News

  42. UTEGENOVA A, Kassymova G, Fakhradiyev I
    EXPERIENCE OF IMPLEMENTING DIGITAL TELEMEDICINE TECHNOLOGIES TO IMPROVE ACCESS TO CERVICAL CANCER SCREENING IN RURAL AREAS OF THE REPUBLIC OF KAZAKHSTAN.
    Georgian Med News. 2025;:187-194.
    PubMed         Abstract available


    Gulf J Oncolog

  43. MISHRA V, Bisht S, Chaudhary S, Pandey L, et al
    Comparative Evaluation of Dosimetric Parameters in Carcinoma Cervix Patients Undergoing Intensity-Modulated Radiotherapy versus Three-Dimensional Radiotherapy: A Retrospective Analysis.
    Gulf J Oncolog. 2025;1:7-12.
    PubMed         Abstract available


    Gynecol Oncol

  44. CHO WK, Park W, Kim SW, Lee KK, et al
    Postoperative hypofractionated intensity-modulated radiation therapy in cervical cancer: prospective phase 2 trial (POHIM_RT study).
    Gynecol Oncol. 2025;198:84-89.
    PubMed         Abstract available


    Health Promot Perspect

  45. KAZEMI S, Zarei F, Hidarnia A, Alhani F, et al
    Efficacy of digital educational intervention using I-Change model in promoting preventive behaviors for cervical cancer among Iranian women: A randomized controlled trial.
    Health Promot Perspect. 2025;15:44-53.
    PubMed         Abstract available


    Health SA

  46. MWANGI JH, Mtshali GN, Mbeje P
    Male partner roles in cervical cancer transmission and prevention in central Kenya: A quantitative approach.
    Health SA. 2025;30:2858.
    PubMed         Abstract available


    Hum Vaccin Immunother

  47. ALSHAHRANI MN, Almutairi D, Zahrani Y, Alsabaani A, et al
    Barriers associated with the parental acceptance of human papillomavirus (HPV) vaccination of minors in Asir, Saudi Arabia: A cross-sectional study.
    Hum Vaccin Immunother. 2025;21:2513708.
    PubMed         Abstract available


    Int J Biol Macromol

  48. QIU J, Xu J, Zhang J, He H, et al
    Exploring the mechanism by which BXSD decoction treats cervical cancer through the combination of network pharmacology and molecular docking analysis: Molecular mechanism of AKT1 and CASP3 protein.
    Int J Biol Macromol. 2025;317.
    PubMed         Abstract available


    Int J Gynecol Cancer

  49. MEI X, Fobian SF, IJff M, Crezee J, et al
    High human papillomavirus viral load and local immune dysregulation are associated with poor clinical outcomes in patients with cervical cancer.
    Int J Gynecol Cancer. 2025;35:101924.
    PubMed         Abstract available

  50. LI J, Cai M, Xie C, Ding S, et al
    Survival outcomes and safety of nimotuzumab combined with radiotherapy +/- chemotherapy for locally advanced cervical cancer.
    Int J Gynecol Cancer. 2025;35:101930.
    PubMed         Abstract available


    Int J Radiat Biol

  51. WANG Y, Wang D, Chen H, Zhang Y, et al
    High HPV viral load predicts worse prognosis in patients with cervical cancer treated with radiochemotherapy.
    Int J Radiat Biol. 2025 Jun 2:1-14. doi: 10.1080/09553002.2025.2510668.
    PubMed         Abstract available


    Int J Radiat Oncol Biol Phys

  52. LINDEGAARD JC, Kirisits C, Schmid MP, Wulff CN, et al
    Impact of patient selection on real-world outcomes by using the EMBRACE-II treatment protocol in locally advanced cervical cancer.
    Int J Radiat Oncol Biol Phys. 2025 Jun 1:S0360-3016(25)00554.
    PubMed         Abstract available


    Int J Surg Pathol

  53. WANG S, Huang X, Zhou X, Chen L, et al
    Endocervical Adenocarcinoma With Micropapillary Component, a Distinct Histological Subtype Associated With Aggressive Behavior and Poor Prognosis: A Clinicopathologic Study of 10 Patients.
    Int J Surg Pathol. 2025;33:801-808.
    PubMed         Abstract available


    Int J Womens Health

  54. ZHANG R, Chai S, Chen Q, Lai J, et al
    The Sensitive Genes for Cervical Cancer: Two-Sample Mendelian Randomization with Experimental Validation.
    Int J Womens Health. 2025;17:1511-1532.
    PubMed         Abstract available


    Intern Med

  55. KOSAKA T, Takaori K, Izumiya A, Hirai D, et al
    Radiation Nephropathy Complicated by Tubulointerstitial Nephritis with Predominantly Lymphocyte and Plasma Cell Infiltration.
    Intern Med. 2025;64:1696-1705.
    PubMed         Abstract available


    J Community Health

  56. PATEL PG, Chowdhury S, Wiener HW, George JT, et al
    Community-level Social Vulnerability and Cervical Cancer Mortality Among Young and Old Adults in the State of Alabama.
    J Community Health. 2025 Jun 1. doi: 10.1007/s10900-025-01482.
    PubMed         Abstract available


    J Gen Intern Med

  57. CLARK CR, Lykken JM, Chen PM, Haas JS, et al
    Barriers to the Equitable Implementation of Risk-Based Cervical Cancer Management Guidelines.
    J Gen Intern Med. 2025 May 30. doi: 10.1007/s11606-025-09611.
    PubMed         Abstract available


    J Korean Med Sci

  58. LEE J, Baek IW, Lim H, Chung MK, et al
    Risk for Human Papillomavirus-Associated Gynecologic Cancers Among Women of Childbearing Age With Rheumatic Diseases: A Population-Based Cohort Study.
    J Korean Med Sci. 2025;40:e95.
    PubMed         Abstract available


    J Nanobiotechnology

  59. JIANG L, Wu T, Qu X, Li S, et al
    Targeting CD39 boosts PD-1 blockade antitumor therapeutic efficacy via strengthening CD8 + TILs function and recruiting B cells in cervical cancer.
    J Nanobiotechnology. 2025;23:413.
    PubMed         Abstract available


    J Natl Cancer Inst

  60. SAIDI SA, Jones MA
    RE: Invasive cervical cancer incidence following bivalent human papillomavirus vaccination: a population-based observational study of age at immunization, dose, and deprivation.
    J Natl Cancer Inst. 2025 Jun 6:djaf130. doi: 10.1093.
    PubMed        


    J Surg Oncol

  61. ZINDANI S, Khalil M, Rashid Z, Altaf A, et al
    Association of Socio-Environmental Burden and Inequality With Cancer Screening and Mortality.
    J Surg Oncol. 2025;131:1110-1117.
    PubMed         Abstract available


    JAMA Intern Med

  62. RITTENBERG E, Richman IB, Corbie G, Gross CP, et al
    HPV Self-Collection for Cervical Cancer Screening-There's No Place Like Home.
    JAMA Intern Med. 2025 Jun 6. doi: 10.1001/jamainternmed.2025.2978.
    PubMed        

  63. MONTEALEGRE JR, Hilsenbeck SG, Bulsara S, Parker SL, et al
    Self-Collection for Cervical Cancer Screening in a Safety-Net Setting: The PRESTIS Randomized Clinical Trial.
    JAMA Intern Med. 2025 Jun 6. doi: 10.1001/jamainternmed.2025.2971.
    PubMed         Abstract available


    JCO Glob Oncol

  64. CONZUELO RODRIGUEZ G, Cremer ML, Muwonge R, Basu P, et al
    Use of Thermal Ablation in Low-Resource Settings: Experience From Three Multicenter Noninferiority Randomized Clinical Trials.
    JCO Glob Oncol. 2025;11:e2500050.
    PubMed         Abstract available


    Jpn J Radiol

  65. OHYA A, Fukuzawa T, Himoto Y, Kido A, et al
    Age-related changes in the radiologic findings of lobular endocervical glandular hyperplasia: a multicenter study.
    Jpn J Radiol. 2025;43:985-994.
    PubMed         Abstract available


    Kathmandu Univ Med J (KUMJ)

  66. DHAKAL M, Basel P
    Prevalence of Depression and Associated Factors among Cervical Cancer Patients Attending Tertiary Center in Bhaktapur, Nepal.
    Kathmandu Univ Med J (KUMJ). 2024;22:385-392.
    PubMed         Abstract available

  67. SHRESTHA A, Poudel L, Khanal B, Poudel K, et al
    Community-based Screening of Cervical Cancer in an Urban Setting in Nepal: A Cross-sectional Study.
    Kathmandu Univ Med J (KUMJ). 2024;22:413-418.
    PubMed         Abstract available


    Laryngorhinootologie

  68. BOOSFELD L, Lang S, Mattheis S, Peis M, et al
    [Diagnosis, treatment and oncological outcome of cervical CUP-syndrome depending on p16 status].
    Laryngorhinootologie. 2025;104:361-370.
    PubMed         Abstract available


    Microbiol Spectr

  69. PU X, Wang X, Wang J, Gu Z, et al
    Microbial and metabolic profiles associated with HPV infection and cervical intraepithelial neoplasia: a multi-omics study.
    Microbiol Spectr. 2025;13:e0019225.
    PubMed         Abstract available


    Mol Diagn Ther

  70. SILVA NNT, Santos ACS, Pereira IOA, da Silva GN, et al
    Cell-Free HPV-DNA in Screening, Diagnosis, Prognosis, and Treatment Response Monitoring of Cervical Cancer.
    Mol Diagn Ther. 2025 Jun 3. doi: 10.1007/s40291-025-00790.
    PubMed         Abstract available


    Mol Med

  71. FAILLACE THIESEN J, Jacquemet E, Campagne P, Chatelain D, et al
    Molecular detection of hrHPV-induced high-grade squamous intraepithelial lesions of the cervix through a targeted RNA next generation sequencing assay.
    Mol Med. 2025;31:215.
    PubMed         Abstract available


    Mol Med Rep

  72. SACHIT BA, Dass SA, Rajan RS, Tye GJ, et al
    Development of an innovative approach for early diagnosis of cervical cancer using TCR?like antibodies targeting HPV18 E6 and E7 peptides.
    Mol Med Rep. 2025;32:218.
    PubMed         Abstract available


    MSMR

  73. GINN M, Stahlman SL, Fan MT, Baker Miller S, et al
    Trends in cervical cancer screening modality in the active component U.S. military, 2013-2023.
    MSMR. 2025;32:14-18.
    PubMed         Abstract available


    Niger J Clin Pract

  74. CIM N, Ayguler E, Gunal N, Cim B, et al
    Systemic Inflammatory Response Index in Cervical Pathologies (Human Papillomavirus and Cervical Neoplasia) and its Prognostic Value in Disease Prediction.
    Niger J Clin Pract. 2025;28:615-623.
    PubMed         Abstract available


    Nucl Med Commun

  75. LEITE E SILVA MH, Barbosa da Silva MA, Dos Santos DSR, Fagundes TC, et al
    PET for predicting chemoradiotherapy survival in cervical cancer: the search continues.
    Nucl Med Commun. 2025 Jun 5. doi: 10.1097/MNM.0000000000001999.
    PubMed         Abstract available


    Phys Med Biol

  76. MASON SA, Wang L, Alexander SE, Lalondrelle S, et al
    Quantitative and automatic plan-of-the-day assessment to facilitate adaptive radiotherapy in cervical cancer.
    Phys Med Biol. 2025 Jun 5. doi: 10.1088/1361-6560.
    PubMed         Abstract available


    PLoS One

  77. ELBASYOUNI A, Kyama MC, El-Shemy HA, Mwitari PG, et al
    Computational investigation and experimental validation of the molecular mechanism of Solanecio mannii aqueous roots extract against cervical cancer.
    PLoS One. 2025;20:e0323680.
    PubMed         Abstract available

  78. ILIC I, Babic G, Sipetic Grujicic S, Zivanovic Macuzic I, et al
    Validity of the process and outcome specific measure in women with abnormal Papanicolaou screening test.
    PLoS One. 2025;20:e0325131.
    PubMed         Abstract available


    Protein Cell

  79. WANG Y, Liang Q, Liang S, Shan Y, et al
    Bardoxolone methyl blocks the efflux of Zn2+ by targeting hZnT1 to inhibit the proliferation and metastasis of cervical cancer.
    Protein Cell. 2025 Jun 5:pwaf044. doi: 10.1093.
    PubMed        


    Radiat Oncol

  80. LIU S, Tan Z, Gong T, Tang X, et al
    Automatic cervical tumors segmentation in PET/MRI by parallel encoder U-net.
    Radiat Oncol. 2025;20:95.
    PubMed         Abstract available


    Semin Oncol Nurs

  81. MULCAHY SYMMONS S, Drury A, De Brun A
    Understanding the Influences of Cervical Screening Attendance among Women of Low Socioeconomic Position Using the Integrated Screening Action Model: A Qualitative Study.
    Semin Oncol Nurs. 2025;41:151891.
    PubMed         Abstract available


    Surg Pract Sci

  82. NIKFAR S, Mousavi AS, Akhavan S, Sheikhhasani S, et al
    Chemo-radiotherapy after neoadjuvant chemotherapy and radical hysterectomy in women with stage IB-IIB cervical cancer: Do we need to change the therapeutic approach? A cohort study.
    Surg Pract Sci. 2025;21:100284.
    PubMed         Abstract available


    Turk J Obstet Gynecol

  83. OZEN S, Demircivi E, Turgut A, Sanci M, et al
    Evaluation of lymph node metastasis in cervical cancer: A retrospective comparison of preoperative MRI and PET/CT with postoperative histopathology results.
    Turk J Obstet Gynecol. 2025;22:129-133.
    PubMed         Abstract available


    Vaccine

  84. SOARES LMC, de Medonca AEO, de Souza DLB, Carvalho AV, et al
    Factors associated with HPV vaccine hesitancy: A nationally representative cross-sectional study.
    Vaccine. 2025;59:127278.
    PubMed         Abstract available

  85. MOHAMED Y, Luey E, Kata ', Tukia O, et al
    "The only vaccine that we really question is the new vaccine": A qualitative exploration of the social and behavioural drivers of human papillomavirus (HPV) vaccination in Tonga.
    Vaccine. 2025;59:127280.
    PubMed         Abstract available


    Virol J

  86. CHEN S, Du Q, Yin J, Xu X, et al
    HPV genotyping agreement between paired cervical cytological sample and biopsy across lesion severity and vaccination.
    Virol J. 2025;22:176.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.